Home › Cancer (all types) › Virginia › Arlington
Cancer (all types) clinical trials in Arlington, VA
52 studies for Cancer (all types) are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi away
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
RecruitingPhase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi away
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RecruitingPhase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi away
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RecruitingPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi away
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
RecruitingPhase 2
- Virginia Cancer Specialists, Fairfax · 11 mi away
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
RecruitingPhase 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · 11 mi away
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
RecruitingPhase 1
- NEXT Virginia ( Site 0054), Fairfax · 11 mi away
PAS-004 in Patients With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology, Fairfax · 11 mi away
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RecruitingPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi away
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 2
- Virginia Cancer Specialists, Fairfax · 11 mi away
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecruitingPhase 1
- Research Site, Fairfax · 11 mi away
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RecruitingPhase 1/2
- NEXT Virginia, Fairfax · 11 mi away
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RecruitingPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi away
A Study of ASP3082 in Adults With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi away
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- NEXT, Fairfax · 11 mi away
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RecruitingPhase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi away
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi away
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 11 mi away
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RecruitingPhase 2
- Next Virginia /ID# 279684, Fairfax · 11 mi away
A Study of PHN-012 in Patients With Advanced Solid Tumors
RecruitingPhase 1
- PHN-012-001 Site, Fairfax · 11 mi away
REC-7735 in Participants With Solid Tumors
RecruitingPhase 1/2
- NEXT Virginia, Fairfax · 11 mi away
Registry Study for Radiation Therapy Outcomes
RecruitingObservational study
- Inova Schar Cancer Institute, Fairfax · 11 mi away
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RecruitingPhase 1
- NEXT Oncology, Fairfax · 11 mi away
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi away
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi away
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology, Fairfax · 11 mi away
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecruitingPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi away
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RecruitingPhase 1
- NEXT Oncology, Fairfax · 11 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Inova Fairfax Hospital, Falls Church · 4 mi away
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
RecruitingPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi away
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RecruitingPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi away
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecruitingPhase 2
- 522, Fairfax · 11 mi away
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi away
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi away
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
RecruitingHealthy volunteers welcome
- Inova Schar Cancer Institute, Fairfax · 11 mi away
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Recruiting
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 11 mi away
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RecruitingPhase 1/2
- NEXT Virginia, Fairfax · 11 mi away
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RecruitingPhase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi away
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi away
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology, Fairfax · 11 mi away
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Virigina, Fairfax · 11 mi away
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RecruitingPhase 1/2
- NEXT Virginia, Fairfax · 11 mi away
A Study in Patients With Advanced Cancers
RecruitingPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX124 studies
- New York City, NY105 studies
- Boston, MA90 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Durham, NC61 studies
- Washington, DC60 studies
- Philadelphia, PA57 studies
- Chicago, IL51 studies
- St. Louis, MO51 studies
- Atlanta, GA49 studies
- Seattle, WA48 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer111 studies
- Colorectal Cancer54 studies
- Metastatic Cancer52 studies
- Breast Cancer50 studies
- Ovarian Cancer47 studies
- Lung Cancer42 studies
- Endometrial Cancer41 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Small Cell Lung Cancer22 studies
- Triple-Negative Breast Cancer21 studies
- Stomach Cancer21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.